Translational Research

Research Translational
GEICO 139-T/ AP 2022 Grant

PI: A. Madariaga

Biomarker discovery with immune spatial characterization in cervical carcinoma
See hospitals
Research Translational
GEICO 140-T/ AP 2022 Grant

PI: A. Barquin

Prospective observational study for the development of artificial intelligence algorithms capable of predicting the evolution of patients with advanced ovarian cancer by integrating their clinical, pathological and molecular characteristics.
See hospitals
Research Translational
GEICO 55-T

PI: JA. Pérez-Fidalgo

Multicentric Single arm Phase II clinical trial, to evaluate safety and efficacy of the combination of Olaparib an PLD for platinum resistant ovarian primary peritoneal carcinoma, and fallopian tube cancer patients: a translational substudy
See hospitals
Research Translational
GEICO 100-T/AP 2020 Grant

PI: A. González

Identification of markers associated with response to PARP inhibitors and immunotherapy in recurrent ovarian cancer.
See hospitals
Research Translational
GEICO 118-T / AP Grant 2022

PI: J. Barretina

Resistance to PARP inhibitors in ovarian cancer: identification of biomarkers using Single Cell technology.
See hospitals
Research Translational
GEICO 119-T/Fellowship AP 2021

PI: JA. Pérez-Fidalgo

Analysis of AXL and its relationship with the immune system as a mechanism of resistance to PARP inhibitors in high-grade ovarian cancer.
See hospitals
Research Translational
GEICO 120-T/DORA

PI: M. Mendiola

Comparison of MSI PCR-based techniques, MMR immunohistochemistry and genetic and alterations as predictive biomarkers for dostarlimab
See hospitals